51 related articles for article (PubMed ID: 38429603)
1. RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.
Ma M; Wang W; Li L; Wang X; Huang Q; Zhou C; Huang Y; Zhao G; Ye L
Transl Oncol; 2024 Aug; 46():102018. PubMed ID: 38838436
[TBL] [Abstract][Full Text] [Related]
2. RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.
Wang R; Tan W
Crit Rev Eukaryot Gene Expr; 2024; 34(5):15-29. PubMed ID: 38842201
[TBL] [Abstract][Full Text] [Related]
3. THE ROLE OF N6-METHYLADENOSINE METHYLTRANSFERASE RBM15 IN NONALCOHOLIC FATTY LIVER DISEASE.
Li S; Lian S; Cheng W; Zhang T; Gong X
Shock; 2024 Feb; 61(2):311-321. PubMed ID: 38150369
[TBL] [Abstract][Full Text] [Related]
4. Identification of m6A modification patterns and RBM15 mediated macrophage phagocytosis in pancreatic cancer: An integrative analysis.
Wang W; He Y; Yao LC; Yuan Y; Lu C; Xiong LK; Ma P; Zhang YF; Yu KH; Tang ZG
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(7):167304. PubMed ID: 38878830
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of m
Hu J; Wang S; Li X
Epigenomics; 2024 Apr; ():1-21. PubMed ID: 38639713
[TBL] [Abstract][Full Text] [Related]
6. The m
Park SH; Ju JS; Woo H; Yun HJ; Lee SB; Kim SH; Győrffy B; Kim EJ; Kim H; Han HD; Eyun SI; Lee JH; Park YY
Exp Mol Med; 2024 Jun; ():. PubMed ID: 38825643
[TBL] [Abstract][Full Text] [Related]
7. The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.
Mao Z; Wang B; Zhang T; Cui B
Cell Death Dis; 2023 Nov; 14(11):734. PubMed ID: 37951987
[TBL] [Abstract][Full Text] [Related]
8. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
9. RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.
Wang H; Li C; Wei Q; Zhang E; Yang Y; Sha L; Wang D
Biochem Genet; 2024 Mar; ():. PubMed ID: 38429603
[TBL] [Abstract][Full Text] [Related]
10. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
11. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
12. RBM15-Mediated m6A Modification of K17 Affects Keratinocytes Response to IL-17A Stimulation in Psoriasis.
Fu M; Zhou B; Shi N; Dong R; Chen Y
Ann Clin Lab Sci; 2023 Jul; 53(4):529-538. PubMed ID: 37625827
[TBL] [Abstract][Full Text] [Related]
13. The RNA m6A writer RBM15 contributes to the progression of esophageal squamous cell carcinoma by regulating miR-3605-5p/KRT4 pathway.
Wang H
Heliyon; 2024 Jan; 10(2):e24459. PubMed ID: 38312624
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
Zhang C; Gu L; Xiao J; Jin F
BMC Cancer; 2023 Jul; 23(1):684. PubMed ID: 37474926
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
